| Financial Year |
March 31 2023 |
| Monetary Funds |
1,070,463,182.29 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
4,106,421.88 |
| Advances to Suppliers |
86,939,060.34 |
| Other Receivables |
9,113,422.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,843,362,442.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
230,896,342.78 |
| Total Current Assets |
3,244,880,872.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
105,417,360.06 |
| Investment Properties |
199,743,946.37 |
| Fixed Assetes |
50,277,514.24 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
23,198,837.97 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,927,770.71 |
| Deferred Income Tax Assets |
1,767,509.39 |
| Other Non-Current Assets |
80,003,850.00 |
| Sub-Total of Non-Current Assets |
1,295,108,968.09 |
| Total Assets |
4,539,989,841.01 |
| Short-Term Loans |
4,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
23,830,589.44 |
| Accounts Received In Advance |
4,343,005.47 |
| Employee Compensation Payable |
269,005.52 |
| Taxes Payable |
694,805,588.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,147,996.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
87,911,982.83 |
| Other Current Liabilities |
544,441.10 |
| Sub-Total of Current Liabilities |
848,979,674.10 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
571,686.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
20,398,846.08 |
| Total Liabilities |
869,378,520.18 |
| Paid-In Capital(Or Share Stock) |
1,602,290,000.00 |
| Capital Surplus |
1,139,159,293.73 |
| Surplus Reserve |
309,323,210.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,196,838,946.25 |
| Minority Stockholder's Interest |
-31,659,505.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,702,270,825.96 |
| Owner's Equity（Stockholder's Equity） |
3,670,611,320.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,539,989,841.01 |
